about
Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinomaThyroid carcinoma with bone metastases: a prognostic factor study.Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach.A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessmentSonographic detection of thyroid cancer in breast cancer patientsPreoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin.Anti-apoptotic effects of protein kinase C-delta and c-fos in cisplatin-treated thyroid cells.Novel therapeutic clues in thyroid carcinomas: The role of targeting cancer stem cells.R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.Usefulness of Stereotactic Radiotherapy Using CyberKnife for Recurrent Lymph Node Metastasis of Differentiated Thyroid Cancer.The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression.Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death.Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake.[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.
P2860
Q34167262-BB0A7028-3F9C-416E-B89C-31CEC1A9B1B0Q35181004-E20C668E-071A-40D7-BB63-3BA3FAFB08CEQ35824783-A66F219F-CDDD-4DF0-B351-65D07C4FCFCAQ36716739-876BBC4E-C898-4C1C-B2C6-96D82093AA59Q37065107-FC4F1FE4-72AC-4D77-BC25-07D05863ECECQ37091804-8B5868F7-FC31-4066-911A-439A05CC3A6EQ37230815-792645B6-B8BB-432C-A4BF-C7BE45AA47EBQ39354316-DA16E7A2-BAB1-4AAA-A8B2-D17049992CC6Q39881718-7FADE55F-EA31-4F34-94BC-212D7295DB11Q41762027-FA4EFB98-DE57-48E4-B6B9-BCC89CB7E50DQ43199707-A044412D-54D7-4B2C-A229-29436CCFD838Q44109526-4435830C-4284-4A98-A2C8-53BCE06FD2BEQ45960402-B6CF9F78-379E-49B5-BDD9-DFCE3852E7DEQ51772441-61985904-650F-4D44-A2D8-B931852115EF
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Management of thyroid cancer.
@ast
Management of thyroid cancer.
@en
Management of thyroid cancer.
@nl
type
label
Management of thyroid cancer.
@ast
Management of thyroid cancer.
@en
Management of thyroid cancer.
@nl
prefLabel
Management of thyroid cancer.
@ast
Management of thyroid cancer.
@en
Management of thyroid cancer.
@nl
P1433
P1476
Management of thyroid cancer.
@en
P2093
Clive Harmer
Louiza Vini
P304
P356
10.1016/S1470-2045(02)00787-8
P577
2002-07-01T00:00:00Z